PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 181 filers reported holding PTC THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.85 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $3,832 | -19.4% | 94,220 | -4.0% | 0.04% | -22.9% |
Q1 2023 | $4,752 | +12.9% | 98,101 | -11.0% | 0.05% | +9.1% |
Q4 2022 | $4,209 | -99.9% | 110,279 | +11.9% | 0.04% | -24.1% |
Q3 2022 | $4,947,000 | -8.0% | 98,530 | -31.7% | 0.06% | +11.5% |
Q1 2022 | $5,380,000 | +18.4% | 144,202 | +26.4% | 0.05% | +30.0% |
Q4 2021 | $4,545,000 | +9.8% | 114,098 | +2.5% | 0.04% | +2.6% |
Q3 2021 | $4,140,000 | -5.4% | 111,269 | +7.4% | 0.04% | -2.5% |
Q2 2021 | $4,378,000 | -18.6% | 103,578 | -8.8% | 0.04% | -24.5% |
Q1 2021 | $5,380,000 | -32.4% | 113,625 | -12.9% | 0.05% | -33.8% |
Q4 2020 | $7,963,000 | +34.4% | 130,488 | +2.9% | 0.08% | +19.4% |
Q3 2020 | $5,927,000 | +2.0% | 126,786 | +10.7% | 0.07% | -2.9% |
Q2 2020 | $5,810,000 | +49.0% | 114,511 | +31.0% | 0.07% | +25.5% |
Q1 2020 | $3,899,000 | +1963.0% | 87,394 | +405.2% | 0.06% | +2650.0% |
Q4 2016 | $189,000 | -21.9% | 17,300 | 0.0% | 0.00% | -33.3% |
Q3 2016 | $242,000 | +100.0% | 17,300 | 0.0% | 0.00% | +50.0% |
Q2 2016 | $121,000 | +9.0% | 17,300 | 0.0% | 0.00% | +100.0% |
Q1 2016 | $111,000 | – | 17,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Burrage Capital Management LLC | 161,083 | $9,831,000 | 7.49% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 333,000 | $20,323,000 | 5.55% |
RTW INVESTMENTS, LP | 4,221,836 | $257,659,000 | 4.32% |
GEORGE KAISER FAMILY FOUNDATION | 90,011 | $10,766,000 | 2.85% |
SECTORAL ASSET MANAGEMENT INC | 603,978 | $36,861,000 | 2.60% |
Redwood Investments, LLC | 364,837 | $22,266,000 | 1.90% |
ARMISTICE CAPITAL, LLC | 716,000 | $43,697,000 | 1.49% |
CM Management, LLC | 25,000 | $1,526,000 | 1.42% |
Third Security, LLC | 237,015 | $14,465,000 | 1.32% |
Sofinnova Investments, Inc. | 316,478 | $19,315,000 | 1.15% |